INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0%
Tue, 26 May

INDRAPRASTHA MEDICAL has announced its results for the quarter ended March 2020. Here is a detailed performance review of the same:

INDRAPRASTHA MEDICAL Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-19*
3
Dec-19*
3
Mar-20*
QoQ ChangeYoY Change
Net SalesRs m2,0042,1042,005-4.7%0.0%
Other incomeRs m21290.1%-31.6%
TurnoverRs m2,0062,1052,007-4.7%0.0%
ExpensesRs m1,8091,8681,830-2.0%1.1%
Gross profitRs m195236175-25.9%-10.0%
DepreciationRs m728482-1.6%14.9%
InterestRs m151412-14.8%-19.4%
Profit before taxRs m11013982-41.0%-25.4%
TaxRs m393217-46.9%-55.8%
Profit after taxRs m7110765-39.2%-9.0%
Gross profit margin%9.711.28.7
Effective tax rate%35.123.120.8
Net profit margin%3.65.13.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 0.0% on a year-on-year (YoY) basis. The expenses were up by 1.1% YoY during the same period.
  • The company's operating profit declined by 10.0% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 8.7% in 4QFY20 as against 9.7% in 4QFY19.
  • Depreciation charges increased by 14.9% and finance costs declined by 19.4% YoY, respectively.
  • Other income declined by 31.6% YoY during the quarter.
  • Net profit for the quarter declined by 9.0% YoY. Net profit margins during the quarter declined from 3.6% in 4QFY19 to 3.2% in 4QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 4.7% on a quarter-on-quarter (QoQ) basis. The expenses were down by 2.0% QoQ during the same period.
  • The company's operating profit declined by 25.9% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 8.7% in 4QFY20 as against 11.2% in 3QFY19.
  • Net profit for the quarter declined by 39.2% QoQ, while net profit margins declined from 5.1% in 3QFY19 to 3.2% in 4QFY20.

To see how INDRAPRASTHA MEDICAL has performed over the last eight quarters,please visit here.

REVEALED: Details of 3 "Super Smallcap" Stocks Nobody Tells You About...

INDRAPRASTHA MEDICAL Share Price Performance

Over the last one year,INDRAPRASTHA MEDICAL share price has moved down from Rs 39.1 to Rs 36.2, registering a Loss of Rs 3.0 or around 7.5%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 15,461.5 (down 0.4%). Over the last one year it has moved up from 13,395.6 to 15,461.5, a gain of 2,066 points (up 15.4%).

Overall, the S&P BSE SENSEX is down 21.6% over the year.

Current Valuations

At the current price of Rs 36.2, the price to earnings (P/E) ratio of INDRAPRASTHA MEDICAL stands at 7.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 1.4 times.

Equitymaster requests your view! Post a comment on "INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0%". Click here!

  

Related Views on News

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL 2018-19 Annual Report Analysis (Annual Result Update)

Oct 18, 2019 | Updated on Oct 18, 2019

Here's an analysis of the annual report of INDRAPRASTHA MEDICAL for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of INDRAPRASTHA MEDICAL. Also includes updates on the valuation of INDRAPRASTHA MEDICAL.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider(Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore(Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market(Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

Revenge Travel is Here. 9 Stocks Likely to Benefit(Views On News)

Sep 4, 2021

The term 'revenge travel' refers to the desire of going on a vacation after an extended period of lockdown.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDRAPRASTHA MEDICAL SHARE PRICE


Sep 17, 2021 12:54 PM

TRACK INDRAPRASTHA MEDICAL

  • Track your investment in INDRAPRASTHA MEDICAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDRAPRASTHA MEDICAL

INDRAPRASTHA MEDICAL 8-QTR ANALYSIS

COMPARE INDRAPRASTHA MEDICAL WITH

MARKET STATS